Friedemann Paul Selected Research

protein kinase C gamma (PRKCG)

4/2021	Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1.
1/2021	Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.
8/2020	Investigation of Visual System Involvement in Spinocerebellar Ataxia Type 14.
8/2015	Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friedemann Paul Research Topics

Disease

111	Multiple Sclerosis 10/2022 - 07/2007
67	Neuromyelitis Optica (Devic's Disease) 04/2022 - 04/2007
33	Optic Neuritis (Retrobulbar Neuritis) 02/2022 - 04/2008
29	Ganglion Cysts (Ganglion) 01/2022 - 08/2015
23	Relapsing-Remitting Multiple Sclerosis 01/2022 - 07/2007
15	Inflammation (Inflammations) 10/2022 - 09/2013
15	Neuroinflammatory Diseases 10/2022 - 05/2013
13	Encephalitis (Encephalitis, Rasmussen) 09/2020 - 01/2013
12	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 09/2013
11	Atrophy 01/2022 - 10/2010
11	Myelitis 11/2020 - 01/2016
9	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2007
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2022 - 09/2013
7	Central Nervous System Diseases (CNS Diseases) 05/2022 - 01/2016
7	Infections 01/2022 - 01/2012
7	Nervous System Diseases (Neurological Disorders) 09/2021 - 11/2010
7	Disease Progression 01/2020 - 10/2014
7	Susac Syndrome 01/2019 - 01/2012
6	Parkinson Disease (Parkinson's Disease) 05/2022 - 08/2014
6	COVID-19 01/2022 - 01/2021
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2013
5	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 04/2021 - 01/2011
5	Encephalomyelitis (Myeloencephalitis) 09/2020 - 12/2009
5	Autoimmune Diseases of the Nervous System 01/2019 - 08/2013
5	Transverse Myelitis (Necrotizing Myelitis) 01/2018 - 04/2007
4	Pain (Aches) 01/2022 - 12/2016
4	Ataxia (Dyssynergia) 01/2021 - 08/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2013
4	Fatigue 01/2018 - 01/2014
3	Dementia (Dementias) 05/2022 - 07/2013
3	Cognitive Dysfunction 11/2021 - 08/2014
3	Neoplasms (Cancer) 09/2021 - 01/2011
3	Multiple System Atrophy 06/2021 - 04/2016
3	Rubella (German Measles) 09/2020 - 08/2015
3	Optic Nerve Diseases (Optic Neuropathy) 12/2018 - 01/2011
3	Vision Disorders (Hemeralopia) 01/2017 - 11/2013
3	Leukocytosis (Pleocytosis) 11/2016 - 01/2012
3	Retinal Artery Occlusion 02/2016 - 06/2013
2	Headache (Headaches) 11/2021 - 10/2015
2	Major Depressive Disorder (Major Depressive Disorders) 11/2021 - 01/2018
2	Stroke (Strokes) 09/2021 - 01/2020
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2018
2	Measles 09/2020 - 09/2020
2	Herpes Zoster 09/2020 - 09/2020

Drug/Important Bio-Agent (IBA)

66	Retinaldehyde (Retinal)IBA 02/2022 - 12/2009
39	Immunoglobulin G (IgG)IBA 03/2022 - 05/2007
35	AntibodiesIBA 04/2022 - 04/2007
26	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2013
26	Myelin-Oligodendrocyte GlycoproteinIBA 04/2022 - 01/2016
18	AutoantibodiesIBA 01/2022 - 09/2011
8	Oligoclonal BandsIBA 01/2022 - 01/2012
8	Proteins (Proteins, Gene)FDA Link 09/2020 - 11/2014
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 08/2013
7	Fingolimod Hydrochloride (FTY720)FDA Link 03/2022 - 11/2013
7	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 01/2015
6	Aquaporins (Water Channels)IBA 09/2020 - 02/2012
6	anti-aquaporin 4 autoantibodyIBA 01/2018 - 09/2010
5	GadoliniumIBA 10/2022 - 07/2017
5	Vitamin D FDA LinkGeneric 01/2020 - 02/2012
5	Natalizumab (Tysabri)FDA Link 01/2020 - 02/2012
4	inebilizumabIBA 01/2022 - 10/2019
4	Complement System Proteins (Complement)IBA 11/2021 - 11/2014
4	Peptides (Polypeptides)IBA 10/2021 - 01/2016
4	protein kinase C gamma (PRKCG)IBA 04/2021 - 08/2015
4	Aquaporin 4IBA 01/2021 - 04/2007
4	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 07/2007
4	Immunoglobulin M (IgM)IBA 09/2020 - 10/2014
4	SteroidsIBA 01/2018 - 06/2016
3	Dihydroorotate DehydrogenaseIBA 01/2022 - 01/2020
3	teriflunomideIBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 12/2015
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
3	VaccinesIBA 01/2022 - 01/2011
3	Polysaccharides (Glycans)IBA 01/2021 - 01/2020
3	Immunoglobulin A (IgA)IBA 09/2020 - 10/2014
3	Therapeutic UsesIBA 01/2020 - 02/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2015
3	EpitopesIBA 10/2016 - 07/2014
2	gadobutrolIBA 10/2022 - 06/2017
2	Gadolinium DTPA (Magnevist)FDA Link 10/2022 - 10/2019
2	pyrimidineIBA 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 01/2017
2	BNT162 VaccineIBA 01/2022 - 10/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2013
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2022 - 12/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2021
2	Rituximab (Mabthera)FDA Link 01/2022 - 11/2018
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022 - 01/2018
2	Biological ProductsIBA 11/2021 - 01/2021
2	Inositol (Myoinositol)IBA 04/2021 - 10/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 01/2013
2	CuprizoneIBA 12/2020 - 01/2017
2	Immunoglobulin IsotypesIBA 09/2020 - 09/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2020 - 09/2020
2	AlbuminsIBA 09/2020 - 09/2020

Therapy/Procedure

26	Therapeutics 03/2022 - 10/2010
8	Immunotherapy 01/2022 - 11/2013
2	Injections 10/2022 - 10/2019
2	Activities of Daily Living (ADL) 01/2021 - 11/2017
2	Transplantation 12/2020 - 01/2011